Dysregulated FABP4 expression in obesity can exacerbate cardiac dysfunction, impact vascular endothelial growth factor (VEGF) secretion (Jabs et al., 2018), and lead to vascular disorders. This evidence concerns the gene VEGFA and obesity disorder.